Abstract:Objective: Early onset drug-resistant epilepsy is a neurologic disorder in which 2 antiepileptic drugs fail to maintain the seizure-free status of the patient. Heterogeneous clinical presentations make the diagnosis challenging. We aim to identify the underlying genetic causes of a pediatric cohort with drug-resistant epilepsy and evaluate whether the findings can provide information on patient management. Methods: We include patients with drug-resistant epilepsy onset before 18 years of age. Singleton clinical chromosomal microarray (CMA) followed by whole exome sequencing (WES) was performed using genomic DNA. In the first-tier analysis of the exome data, we aimed to identify disease-causing mutations in 546 genes known to cause, or to be associated with, epilepsy. For negative cases, we proceeded to exome-wide analysis. Rare coding variants were interrogated for pathogenicity based on the American College of Medical Genetics and Genomics (ACMG) guidelines. Results: We recruited 50 patients. We identified 6 pathogenic or likely pathogenic mutations, giving a diagnostic yield of 12%. Mutations were found in 6 different genes: SCN8A, SCN1A, MECP2, CDKL5, DEPDC5, and CHD2. The CDKL5 variant was found to be mosaic. One variant of unknown significance (VUS) in KCNT1 was found in a patient with compatible clinical features. Of note, a reported pathogenic SCN5A mutation known to contribute to Brugada syndrome, was also found in the patient with an SCN1A mutation. Significance: Our study suggests that singleton WES is an effective diagnostic tool for drug-resistant epilepsy. Genetic diagnosis can help to consolidate the clinical diagnosis, to facilitate phenotypic expansion, and to influence treatment and management options for seizure control in our patients. In our study, a significant portion of the genetic findings are known to be associated with an increased risk of sudden unexpected death in epilepsy (SUDEP). These findings could assist with more appropriate management in patients with epilepsy.

THz bandwidth optical switching with carbon nanotube metamaterial.

Clinical and Molecular Analysis of Epilepsy-Related Genes in Patients with Dravet Syndrome

Clinical and Genetic Spectrum of a Large Cohort of Children with Epilepsy in China

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

Genetic and Phenotype Analysis of a Chinese Cohort of Infants and Children With Epilepsy

Common genes and recurrent causative variants in 957 Asian patients with pediatric epilepsy

Genotype and Phenotype Analysis Using an Epilepsy‐associated Gene Panel in Chinese Pediatric Epilepsy Patients

Exome sequencing identifies molecular diagnosis in children with drug-resistant epilepsy

High Genetic Burden in 163 Chinese Children with Status Epilepticus

Next Generation Sequencing in Children with Unexplained Epilepsy: A Retrospective Cohort Study.

Novel Mutations and Phenotypes of Epilepsy-Associated Genes in Epileptic Encephalopathies.

Gene Mutational Analysis in a Cohort of Chinese Children with Unexplained Epilepsy: Identification of a New KCND3 Phenotype and Novel Genes Causing Dravet Syndrome

Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes

Identification of genetic causes in children with unexplained epilepsy based on trio‐whole exome sequencing

Epilepsies of presumed genetic etiology show enrichment of rare variants that occur in the general population

Antihyperalgesic effect of 5-HT7 receptor activation on the midbrain periaqueductal gray in a rat model of neuropathic pain

Genetic Spectrum Identified by Exome Sequencing in a Chinese Pediatric Cerebral Palsy Cohort

Next-generation sequencing testing in children with epilepsy reveals novel clinical, diagnostic and therapeutic implications

Gene Mutation Analysis In 253 Chinese Children With Unexplained Epilepsy And Intellectual/Developmental Disabilities

Novel and de novo mutations in pediatric refractory epilepsy

[Clinical Features and Genome-Wide Copy Number Variation Analysis in 60 Children with Early-Onset Epileptic Encephalopathies of Unknown Cause].